Showing results (31-40 of 56) with videos related to
Sort By:
Pageof 6
International Immunopharmacology|February 2, 2026
Mechanism of vildagliptin-induced liver injury: An idiosyncratic drug reaction mediated by inflammasome activationSerina Mizuguchi, Saori Tanaka, Rei Aoki, et al.Cancers|December 11, 2022
Tumor Location and a Tumor Volume over 2.8 cc Predict the Prognosis for Japanese Localized Prostate CancerHaruki Baba, Shinichi Sakamoto, Xue Zhao, et al.Journal of Occupational Health|February 2, 2021
Anticipated health effects and proposed countermeasures following the immediate introduction of telework in response to the spread of COVID-19: The findings of a rapid health impact assessment in JapanTomohisa Nagata, Daisuke Ito, Masako Nagata, et al.The Prostate|December 10, 2019
Higher serum testosterone levels predict poor prognosis in castration-resistant prostate cancer patients treated with docetaxelKeisuke Ando, Shinichi Sakamoto, Nobushige Takeshita, et al.Journal of Gastrointestinal Cancer|May 25, 2026
Association of Probiotics with Effectiveness of Nivolumab or Pembrolizumab in Patients with Esophageal Cancer Taking Proton Pump Inhibitors: A Multicenter Retrospective StudyAyumi Fujimoto, Ryuji Uozumi, Hironori Fujii, et al.Cancer Science|December 20, 2025
Impact of Achieving Progression-Free Survival 24 on Subsequent Overall Survival in Diffuse Large B-Cell Lymphoma PatientsAyumi Fujimoto, Wataru Munakata, Gakuto Ogawa, et al.Scientific Reports|June 21, 2023
Tumor localization by Prostate Imaging and Reporting and Data System (PI-RADS) version 2.1 predicts prognosis of prostate cancer after radical prostatectomyAyumi Fujimoto, Shinichi Sakamoto, Takuro Horikoshi, et al.Journal of Clinical Pharmacy and Therapeutics|October 22, 2020
Population pharmacokinetics of tacrolimus in umbilical cord blood transplant patients focusing on the variation in red blood cell countsSaki Yoshida, Ayumi Fujimoto, Keizo Fukushima, et al.Biopharmaceutics & Drug Disposition|June 21, 2019
Interaction of platinum agents, cisplatin, carboplatin and oxaliplatin against albumin in vivo rats and in vitro study using inductively coupled plasma-mass spectrometoryRyuji Kato, Takaji Sato, Asuka Iwamoto, et al.Leukemia|January 7, 2026
Advances in the treatment and prognosis of aggressive NK-cell leukemia: results from the ANKL22 studyAyumi Fujimoto, Takeshi Maeda, Noriko Doki, et al.Pageof 6